z-logo
open-access-imgOpen Access
Ropivacaine represses the ovarian cancer cell stemness and facilitates cell ferroptosis through inactivating the PI3K/AKT signaling pathway
Author(s) -
Yi Lü,
Jinbao Mao,
Yanyan Xu,
Hao Pan,
Yu Wang,
Wei Li
Publication year - 2022
Publication title -
human and experimental toxicology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.572
H-Index - 78
eISSN - 1477-0903
pISSN - 0960-3271
DOI - 10.1177/09603271221120652
Subject(s) - ovarian cancer , ropivacaine , pi3k/akt/mtor pathway , cancer research , protein kinase b , cell growth , cancer cell , cancer , medicine , in vivo , biology , pharmacology , signal transduction , microbiology and biotechnology , biochemistry

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here